Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Intermittent fasting has become popular in recent years and is controversially presented as a possible therapeutic adjunct. A bibliographic review of the literature on intermittent fasting and obesity, diabetes, and multiple sclerosis was carried out. The scientific quality of the methodology and the results obtained were evaluated in pairs. Intermittent fasting has beneficial effects on the lipid profile, and it is associated with weight loss and a modification of the distribution of abdominal fat in people with obesity and type 2 diabetes as well as an improvement in the control of glycemic levels. In patients with multiple sclerosis, the data available are too scarce to draw any firm conclusions, but it does appear that intermittent fasting may be a safe and feasible intervention. However, it is necessary to continue investigating its long-term effects since so far, the studies carried out are small and of short duration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Sutton, E. F., Beyl, R., Early, K. S., Cefalu, W. T., Ravussin, E., & Peterson, C. M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.010 · Cited by 1,531
Jamshed, H., Beyl, R., Della Manna, D., Yang, E., Ravussin, E., & Peterson, C. (2019) · Nutrients · doi:10.3390/nu11061234 · Cited by 664
Stekovic, S., Hofer, S. J., Tripolt, N., Aon, M. A., Royer, P., Pein, L., Stadler, J. T., Pendl, T., Prietl, B., Url, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.016 · Cited by 412
Harris, L., Hamilton, S., Azevedo, L. B., Olajide, J., De Brún, C., Waller, G., Whittaker, V., Sharp, T., Lean, M., Hankey, C., et al. (2018) · JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2016-003248 · Cited by 319 · cited 3×
“waist circumference and central fat distribution, both of which are beneficial since these parameters are important in reducing cardiovascular risk [13,14,17,19,22,25,26,29].”
BackgroundMethodIntermittent Fasting in Cardiovascular Disorders—An Overview
Malinowski, B., Zalewska, K., Węsierska, A., Sokołowska, M. M., Socha, M., Liczner, G., Pawlak-Osińska, K., & Wiciński, M. (2019) · Nutrients · doi:10.3390/nu11030673 · Cited by 290 · cited 4×
“High levels of ketones reduce oxidative stress [8,15,21], preserve lean mass [27,28], and have other metabolic effects, such as decreased hunger.”
BackgroundInfluentialMeng, H., Zhu, L., Kord-Varkaneh, H., O Santos, H., Tinsley, G. M., & Fu, P. (2020) · Nutrition · doi:10.1016/j.nut.2020.110801 · Cited by 146 · cited 3×
“1− A Meng et al., 2020 [32] Shandog, China Systematic review with meta-analysis Randomized clinical trials or randomized clinical trials with high risk of bias To summarize the effects of controlled clinical trials examining the influence of IF and dietary restriction diets on lipid profiles.”
BackgroundLi, C., Sadraie, B., Steckhan, N., Kessler, C., Stange, R., Jeitler, M., & Michalsen, A. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-101700 · Cited by 113 · cited 4×
“with obesity and people with type 2 diabetes [17,24,29].”
BackgroundMethodInfluentialPark, J., Seo, Y.-G., Paek, Y.-J., Song, H. J., Park, K. H., & Noh, H.-M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154336 · Cited by 93 · cited 4×
“with obesity and people with type 2 diabetes [17,24,29].”
BackgroundInfluential
Cited by
Beneficial Effects of Intermittent Fasting: A Narrative Review
Song, D.-K., & Kim, Y.-W. (2023) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2022.00010 · Cited by 69
Lange, M., Nadkarni, D., Martin, L., Newberry, C., Kumar, S., & Kushner, T. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000212 · Cited by 49
Ezzati, A., Rosenkranz, S. K., Phelan, J., & Logan, C. (2023) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.09.013 · Cited by 45
Can Circadian Eating Pattern Adjustments Reduce Risk or Prevent Development of T2D?
Harris, C., & Czaja, K. (2023) · Nutrients · doi:10.3390/nu15071762 · Cited by 13
Wu, C., Chen, B., Yu, J., Zhang, Q., & Piao, C. (2025) · International Journal of Endocrinology · doi:10.1155/ije/6658512 · Cited by 6
Metadata
- Authors
- Morales-Suarez-Varela, M., Collado Sánchez, E., Peraita-Costa, I., Llopis-Morales, A., & Soriano, J. M.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-09-13
- Volume
- 13
- Issue
- 9
- Pages
- 3179
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W3201346034
- Cited by
- 84
- References
- 9
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials. https://app.cochat.ai/papers/10.3390/nu13093179
- The paper
- Morales-Suarez-Varela, M., Collado Sánchez, E., Peraita-Costa, I., Llopis-Morales, A., & Soriano, J. M. (2021). Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials. Nutrients. https://doi.org/10.3390/nu13093179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.